fbpx

U.S. Anti-Doping Agency (USADA)

Click here for the Athlete Connect application

USADA logo.

Global DRO logo in whiteSearch Medications & Ingredients

Search
Search
Close this search box.

Brazilian Jiu-Jitsu Athlete Felipe Pena Accepts Sanction for Second Anti-Doping Rule Violation

Two Brazilian Jiu-Jitsu athletes competingUSADA announced today that Felipe Pena, of Minas Gerais, Brazil, an athlete in the sport of Brazilian Jiu-Jitsu, has accepted a one-year period of ineligibility for his second anti-doping rule violation. Pena’s first violation was announced in 2015.

Pena, 30, tested positive for clomiphene and its metabolites as the result of an in-competition drug test conducted at the 2021 International Brazilian Jiu-Jitsu Federation (IBJJF) World Jiu-Jitsu Championships on December 12, 2021. Although the IBJJF is not a signatory to the World Anti-Doping Code, USADA was contracted by IBJJF to conduct testing for the event.

Clomiphene is a Specified Substance in the class of Hormone and Metabolic Modulators and is prohibited at all times under the World Anti-Doping Code and the USADA Protocol for Olympic and Paralympic Movement Testing, which applied to the 2021 IBJJF World Jiu-Jitsu Championships.

Pena’s one-year period of ineligibility began on January 7, 2022, the date his provisional suspension was imposed. In addition, Pena has been disqualified from all competitive results achieved in competitions sanctioned by the IBJJF, or any Code signatory, on and subsequent to December 12, 2021, the date his positive sample was collected, including forfeiture of any medals, points, and prizes. IBJJF has agreed to impose the sanction.

In an effort to aid athletes, as well as support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to file and update athlete Whereabouts, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements, as well as performance-enhancing and recreational drugs.

In addition, USADA manages a drug reference hotline, Global Drug Reference Online (www.GlobalDRO.com), conducts educational sessions with National Governing Bodies and their athletes, and distributes a multitude of educational materials, such as a supplement guide, a nutrition guide, a clean sport handbook, and periodic alerts and advisories.

USADA makes available a number of ways to report the abuse of performance-enhancing drugs in sport in an effort to protect clean athletes and promote clean competition. Any tip can be reported using the USADA Play Clean Tip Center, by text at 87232 (“USADA”), by email at playclean@USADA.org, by phone at 1-877-Play Clean (1-877-752-9253) or by mail.

USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs.


For more information or media inquiries, click here.